Phase Ib-II Study of Post-Transplant Cyclophosphamide, Abatacept and Short Course of Tacrolimus (CAST) for Graft-Versus-Host Disease Prevention Following Haploidentical Peripheral Blood Stem Cell Transplantation
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: A Samer Al-Homsi, Frank Cirrone, Kelli Cole, J Andres-Suarez Londono, Sharon Gardner, Jingmei Hsu, Stephanie Wo, Kelsey Stocker, Judith Goldberg, Benjamin Levinson, Maher Abdul-Hay Tags: POSTER SESSION: GRAFT-VERSUS-HOST AND GRAFT VERSUS TUMOR - CLINICAL: PREVENTION, TREATMENT AND BIOMARKERS Source Type: research
More News: Abatacept | Biology | Hematology | Orencia | Prograf | Stem Cell Therapy | Stem Cells | Study | Tacrolimus | Transplants